These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9198452)

  • 21. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.
    Perneczky R; Pohl C; Sorg C; Hartmann J; Komossa K; Alexopoulos P; Wagenpfeil S; Kurz A
    Age Ageing; 2006 May; 35(3):240-5. PubMed ID: 16513677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardization of the Alzheimer's Disease Assessment Scale in a Spanish population].
    Pascual LF; Saz P; Larumbe R; Martínez-Lage P; Muruzábal J; Morales F; Lobo A; Martínez-Lage JM; Sastre y Hernández M
    Neurologia; 1997; 12(6):238-44. PubMed ID: 9303590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of 6-month decline in ADAS-cog for survival without severe Alzheimer's disease.
    Helmer C; Andrieu S; Pérès K; Orgogozo JM; Vellas B; Dartigues JF;
    Dement Geriatr Cogn Disord; 2007; 23(3):168-74. PubMed ID: 17215578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical validity of two scales of instrumental activities in Alzheimer's disease].
    Olazarán J; Mouronte P; Bermejo F
    Neurologia; 2005 Oct; 20(8):395-401. PubMed ID: 16217688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subjective complaints and self-evaluation of memory test performance in Questionable dementia.
    Wong CH; Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):937-44. PubMed ID: 16927400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of the Korean version of Alzheimer's Disease Assessment Scale (ADAS-K).
    Youn JC; Lee DY; Kim KW; Lee JH; Jhoo JH; Lee KU; Ha J; Woo JI
    Int J Geriatr Psychiatry; 2002 Sep; 17(9):797-803. PubMed ID: 12221651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease].
    Serrano C; Allegri RF; Drake M; Butman J; Harris P; Nagle C; Ranalli C
    Rev Neurol; 2001 Oct 1-15; 33(7):624-7. PubMed ID: 11784949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
    Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Japanese version of the Frontal Assessment Battery for dementia.
    Kugo A; Terada S; Ata T; Ido Y; Kado Y; Ishihara T; Hikiji M; Fujisawa Y; Sasaki K; Kuroda S
    Psychiatry Res; 2007 Sep; 153(1):69-75. PubMed ID: 17599465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Shortened version of the Barcelona test (II): global standard score].
    Guardia J; Peña-Casanova J; Bertran-Serra I; Manero RM; Meza M; Böhm P; Espel G; Martí A
    Neurologia; 1997 Mar; 12(3):112-6. PubMed ID: 9198451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reliability and validity of the Cornell Scale for Depression in Dementia in an elderly Turkish population].
    Amuk T; Karadağ F; Oğuzhanoğlu N; Oğuzhanoğlu A
    Turk Psikiyatri Derg; 2003; 14(4):263-71. PubMed ID: 14704928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences with the Eurotest in neuropsychological examinations. A screening test].
    Peset V; Puig C; Martínez-Ruiz E; Mazón J; Menéndez B; Lacruz-Ballester L; Lluch V; Lominchar-Espada J
    Rev Neurol; 2007 Jul 1-15; 45(1):22-6. PubMed ID: 17620262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.